RedHill Biopharma Ltd Stock TEL AVIV STOCK EXCHANGE
Equities
IL0011223810
Pharmaceuticals
Sales 2022 | 61.8M 23.23B | Sales 2023 | 6.53M 2.45B | Capitalization | 28.72M 10.8B |
---|---|---|---|---|---|
Net income 2022 | -71M -26.69B | Net income 2023 | 23M 8.65B | EV / Sales 2022 | 1.87 x |
Net Debt 2022 | 103M 38.61B | Net cash position 2023 | 4.4M 1.65B | EV / Sales 2023 | 3.73 x |
P/E ratio 2022 |
-0.12
x | P/E ratio 2023 |
0.4
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 99% |
Managers | Title | Age | Since |
---|---|---|---|
Dror Ben-Asher
CEO | Chief Executive Officer | 59 | 09-08-02 |
Ori Shilo
FOU | Founder | 57 | 09-08-02 |
Razi Ingber
DFI | Director of Finance/CFO | - | 23-01-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rick Scruggs
BRD | Director/Board Member | 64 | 15-12-31 |
Shmuel Cabilly
BRD | Director/Board Member | 74 | 10-08-25 |
Director/Board Member | 80 | 10-05-02 |
1st Jan change | Capi. | |
---|---|---|
-5.99% | 84.46B | |
+2.76% | 40.85B | |
-24.88% | 27.69B | |
+53.61% | 24.28B | |
-8.08% | 17.09B | |
-33.74% | 13.67B | |
-16.63% | 11.86B | |
-11.19% | 11.79B | |
-2.25% | 8.07B |